image
Healthcare - Biotechnology - NASDAQ - US
$ 0.79
-1.64 %
$ 102 M
Market Cap
-3.95
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
55.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Atossa Therapeutics, Inc.
image
ATOS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ATOS

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02015201520232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ATOS

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)2015201520232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ATOS

image
$2.0b$2.0b$0.0$0.0($2.0b)($2.0b)($4.0b)($4.0b)($6.0b)($6.0b)($8.0b)($8.0b)($10.0b)($10.0b)($12.0b)($12.0b)2015201520232023202420242025202520262026202720272028202820292029